IKK-2 Inhibitor VI (CAS 354811-10-2)
See product citations (5)
QUICK LINKS
IKK-2 Inhibitor VI is a chemical compound specifically designed to target and inhibit the activity of IKK-2, which stands for Inhibitor of KappaB Kinase-2. This enzyme plays a significant role in the NF-kappaB (nuclear factor kappa-light-chain-enhancer of activated B cells) signaling pathway, which is involved in the regulation of various cellular processes. The inhibition of IKK-2 by IKK-2 Inhibitor VI can therefore be of particular interest in research applications where scientists are studying the NF-kappaB pathway, which is known to be involved in responses to stimuli such as stress, cytokines, free radicals, ultraviolet irradiation, and bacterial or viral antigens. By preventing the activation of NF-kappaB through IKK-2 inhibition, researchers can gain insights into the role of this pathway in cellular signaling and the expression of specific genes.
IKK-2 Inhibitor VI (CAS 354811-10-2) References
- Hit-to-lead studies: the discovery of potent, orally active, thiophenecarboxamide IKK-2 inhibitors. | Baxter, A., et al. 2004. Bioorg Med Chem Lett. 14: 2817-22. PMID: 15125939
- Curcumin inhibits the formation of capillary-like tubes by rat lymphatic endothelial cells. | Matsuo, M., et al. 2007. Cancer Lett. 251: 288-95. PMID: 17197075
- Synergistic up-regulation of prostaglandin E synthase expression in breast cancer cells by 17beta-estradiol and proinflammatory cytokines. | Frasor, J., et al. 2008. Endocrinology. 149: 6272-9. PMID: 18703630
- TRAF6 and MEKK1 play a pivotal role in the RIG-I-like helicase antiviral pathway. | Yoshida, R., et al. 2008. J Biol Chem. 283: 36211-20. PMID: 18984593
- Activation of NF-kappaB signaling by inhibitor of NF-kappaB kinase beta increases aggressiveness of ovarian cancer. | Hernandez, L., et al. 2010. Cancer Res. 70: 4005-14. PMID: 20424119
- High-cell density-induced VCAM1 expression inhibits the migratory ability of mesenchymal stem cells. | Nishihira, S., et al. 2011. Cell Biol Int. 35: 475-81. PMID: 21073443
- Cell-cell adhesion through N-cadherin enhances VCAM-1 expression via PDGFRβ in a ligand-independent manner in mesenchymal stem cells. | Aomatsu, E., et al. 2014. Int J Mol Med. 33: 565-72. PMID: 24378362
- Preclinical Characterization of BET Family Bromodomain Inhibitor ABBV-075 Suggests Combination Therapeutic Strategies. | Bui, MH., et al. 2017. Cancer Res. 77: 2976-2989. PMID: 28416490
- CXCL12γ Promotes Metastatic Castration-Resistant Prostate Cancer by Inducing Cancer Stem Cell and Neuroendocrine Phenotypes. | Jung, Y., et al. 2018. Cancer Res. 78: 2026-2039. PMID: 29431639
- The lncRNA BORG facilitates the survival and chemoresistance of triple-negative breast cancers. | Gooding, AJ., et al. 2019. Oncogene. 38: 2020-2041. PMID: 30467380
- The effect of NLRP inflammasome on the regulation of AGEs-induced inflammatory response in human periodontal ligament cells. | Yi, X., et al. 2019. J Periodontal Res. 54: 681-689. PMID: 31250434
- Occlusal trauma inhibits osteoblast differentiation and bone formation through IKK-NF-κB signaling. | Xu, W., et al. 2020. J Periodontol. 91: 683-692. PMID: 31487049
- SLX4IP promotes RAP1 SUMOylation by PIAS1 to coordinate telomere maintenance through NF-κB and Notch signaling. | Robinson, NJ., et al. 2021. Sci Signal. 14: PMID: 34187905
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
IKK-2 Inhibitor VI, 1 mg | sc-221743 | 1 mg | $181.00 | |||
IKK-2 Inhibitor VI, 2.5 mg | sc-221743A | 2.5 mg | $328.00 |